Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
0.4347
-0.0383 (-8.10%)
At close: Feb 23, 2026, 4:00 PM EST
0.4237
-0.0110 (-2.53%)
After-hours: Feb 23, 2026, 7:07 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $17.73 million as of February 23, 2026. Its market cap has decreased by -56.46% in one year.
Market Cap
17.73M
Enterprise Value
8.69M
1-Year Change
-56.46%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $17.73M, a decrease of -89.11%. That is a compound annual growth rate of -37.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 19.29M | -53.51% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
| May 7, 2021 | 162.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 22.82M |
| Senti Biosciences | 22.61M |
| Vistagen Therapeutics | 22.15M |
| NanoViricides | 22.03M |
| Polyrizon | 20.75M |
| VYNE Therapeutics | 19.80M |
| Klotho Neurosciences | 18.58M |
| Pasithea Therapeutics | 18.47M |